HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kerstin Amann Selected Research

Triamterene (Dyrenium)

1/2021Zymogen-locked mutant prostasin (Prss8) leads to incomplete proteolytic activation of the epithelial sodium channel (ENaC) and severely compromises triamterene tolerance in mice.
1/2009Responses to diuretic treatment in gene-targeted mice lacking serum- and glucocorticoid-inducible kinase 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kerstin Amann Research Topics

Disease

41Fibrosis (Cirrhosis)
11/2022 - 01/2002
32Hypertension (High Blood Pressure)
01/2021 - 01/2003
29Proteinuria
01/2022 - 12/2004
27Inflammation (Inflammations)
05/2022 - 09/2005
20Glomerulonephritis
01/2022 - 08/2000
18Renal Insufficiency (Renal Failure)
01/2021 - 10/2001
17Albuminuria
01/2022 - 10/2003
16Neoplasms (Cancer)
01/2021 - 06/2004
16Body Weight (Weight, Body)
01/2021 - 05/2002
15Hypertrophy
11/2017 - 05/2002
14Nephritis
01/2021 - 08/2000
13Atherosclerosis
11/2017 - 02/2003
12Chronic Renal Insufficiency
11/2022 - 05/2002
11Chronic Kidney Failure (Chronic Renal Failure)
01/2019 - 08/2002
11Hypoxia (Hypoxemia)
08/2015 - 07/2006
10Kidney Diseases (Kidney Disease)
01/2022 - 10/2008
10Diabetic Nephropathies (Diabetic Nephropathy)
11/2018 - 12/2007
9Acute Kidney Injury (Acute Renal Failure)
01/2022 - 07/2006
9Nephrotic Syndrome (Syndrome, Nephrotic)
01/2021 - 12/2007
9Lupus Nephritis
01/2018 - 10/2007
9Systemic Lupus Erythematosus (Libman-Sacks Disease)
02/2015 - 08/2006
8Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2022 - 11/2009
7Osteonecrosis (Kienbock's Disease)
01/2021 - 03/2005
7Necrosis
01/2021 - 05/2006
7Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
02/2019 - 02/2009
7Carcinoma (Carcinomatosis)
07/2015 - 01/2002
6Infections
01/2022 - 10/2006
6Thrombotic Microangiopathies
01/2022 - 02/2009
6Uremia
10/2019 - 10/2001
6Diabetes Mellitus
04/2012 - 04/2009
5Renovascular Hypertension (Goldblatt Syndrome)
12/2021 - 01/2003
5Membranous Glomerulonephritis (Membranous Nephropathy)
11/2021 - 05/2016
5Type 2 Diabetes Mellitus (MODY)
01/2021 - 09/2003
5IGA Glomerulonephritis (IGA Nephropathy)
03/2020 - 01/2016
5Nephrosclerosis
01/2020 - 07/2008
5Ischemia
01/2020 - 05/2009
5Cardiovascular Diseases (Cardiovascular Disease)
10/2019 - 11/2009
5Osteoradionecrosis
01/2019 - 03/2005
4Interstitial Nephritis (Tubulointerstitial Nephritis)
01/2022 - 10/2012
4Malignant Hypertension
12/2021 - 05/2010
4Edema (Dropsy)
11/2021 - 05/2008
4Wounds and Injuries (Trauma)
01/2021 - 09/2004
4Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
01/2021 - 07/2010
4Thrombosis (Thrombus)
01/2020 - 10/2004
4Vascular Remodeling
01/2020 - 10/2001
4Vascular Calcification
06/2019 - 11/2008

Drug/Important Bio-Agent (IBA)

40Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2002
14salicylhydroxamic acid (SHAM)IBA
12/2021 - 09/2002
14SaltsIBA
01/2021 - 01/2003
14CreatinineIBA
01/2018 - 09/2005
12Complement System Proteins (Complement)IBA
01/2022 - 06/2013
11Transcription Factors (Transcription Factor)IBA
01/2016 - 07/2006
10AutoantibodiesIBA
11/2021 - 10/2007
10AntibodiesIBA
12/2020 - 04/2004
10CytokinesIBA
11/2016 - 01/2002
10Transforming Growth Factor beta (TGF-beta)IBA
06/2015 - 01/2002
9Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2018 - 12/2001
8SodiumIBA
01/2022 - 03/2005
8EnzymesIBA
02/2016 - 10/2005
7CollagenIBA
01/2022 - 07/2008
7Diphosphonates (Bisphosphonates)IBA
01/2021 - 10/2010
7Glucose (Dextrose)FDA LinkGeneric
01/2021 - 10/2005
7Messenger RNA (mRNA)IBA
11/2018 - 09/2002
7Urea (Carbamide)FDA LinkGeneric
01/2018 - 09/2006
7LipidsIBA
07/2016 - 02/2003
6Antigen-Antibody Complex (Immune Complex)IBA
05/2022 - 04/2010
6Apolipoproteins E (ApoE)IBA
09/2021 - 02/2003
6Pharmaceutical PreparationsIBA
01/2021 - 01/2011
6DNA (Deoxyribonucleic Acid)IBA
01/2021 - 08/2006
6Oxygen (Dioxygen)IBA
08/2015 - 09/2002
5RNA (Ribonucleic Acid)IBA
12/2021 - 02/2002
5SteroidsIBA
01/2021 - 09/2005
5CalciumIBA
01/2021 - 04/2003
5Desoxycorticosterone Acetate (DOCA)FDA Link
01/2021 - 01/2006
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2018 - 01/2006
5ApolipoproteinsIBA
01/2018 - 02/2003
5Angiotensin IIIBA
12/2017 - 01/2006
5Endothelins (Endothelin)IBA
01/2007 - 12/2001
4AlbuminsIBA
11/2022 - 08/2006
4LectinsIBA
01/2022 - 01/2006
4Complement Membrane Attack Complex (Membrane Attack Complex)IBA
01/2022 - 01/2007
4Peptides (Polypeptides)IBA
09/2021 - 12/2004
4Biomarkers (Surrogate Marker)IBA
07/2021 - 02/2015
4candesartanIBA
01/2021 - 01/2009
4antiglomerular basement membrane antibodyIBA
01/2021 - 01/2013
4Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2018 - 05/2002
4ReninIBA
01/2017 - 12/2001
4Estrogen ReceptorsIBA
11/2016 - 02/2009
4GTP-Binding Proteins (G-Protein)IBA
11/2016 - 02/2009
4Protein Isoforms (Isoforms)IBA
11/2016 - 08/2002
4Phosphotransferases (Kinase)IBA
11/2016 - 01/2006

Therapy/Procedure

32Therapeutics
01/2022 - 05/2002
11Nephrectomy
01/2021 - 09/2002
10Kidney Transplantation
06/2021 - 11/2009
7Surgical Instruments (Clip)
12/2021 - 01/2003
6Radiotherapy
11/2017 - 01/2002
4Transplantation
03/2021 - 05/2005
4Liver Transplantation
01/2021 - 10/2004
4Intravenous Injections
11/2020 - 05/2009
4Ligation
04/2017 - 01/2010